WHO Update: Guidelines for the treatment of malaria

EXTERNAL PUBLICATION
April 2011
WHO now recommends parenteral artesunate as first line treatment in the management of severe falciparum malaria in african children.


Box 8.1a
Recommendation: IV/IM artesunate treatment for severe P. falciparum malaria in adults

Intravenous artesunate should be used in preference to quinine for the treatment of severe P. falciparum malaria in adults. Strong recommendation, high quality evidence.  

Box 8.1b
Recommendation: IV/IM artesunate treatment for severe P. falciparum malaria in children 

Intravenous artesunate should be used in preference to quinine for the treatment of severe P. falciparum malaria in children. Strong recommendation, high quality evidence.